97 related articles for article (PubMed ID: 6836735)
1. Overpromotion of drugs in international product package inserts.
Osifo NG
Trop Doct; 1983 Jan; 13(1):5-8. PubMed ID: 6836735
[TBL] [Abstract][Full Text] [Related]
2. Overpromotion of drugs in international product package inserts.
Saxton C
Trop Doct; 1983 Oct; 13(4):168-70. PubMed ID: 6649040
[No Abstract] [Full Text] [Related]
3. The Physicians' Desk Reference. Problems and possible improvements.
Cohen JS; Insel PA
Arch Intern Med; 1996 Jul; 156(13):1375-80. PubMed ID: 8678706
[TBL] [Abstract][Full Text] [Related]
4. Clinical information in drug package inserts in India.
Shivkar YM
J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
[TBL] [Abstract][Full Text] [Related]
5. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
Uhl K; Kennedy DL; Kweder SL
Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129
[TBL] [Abstract][Full Text] [Related]
6. Drug promotion and labeling in developing countries: an update.
Lee PR; Lurie P; Silverman MM; Lydecker M
J Clin Epidemiol; 1991; 44 Suppl 2():49S-55S. PubMed ID: 2045842
[TBL] [Abstract][Full Text] [Related]
7. The drugging of the Third World.
Silverman M; Lee PR; Lydecker M
Int J Health Serv; 1982; 12(4):585-96. PubMed ID: 7141775
[TBL] [Abstract][Full Text] [Related]
8. [(Mis)information on drugs: the double standard practiced by pharmaceutical companies].
Barros JA
Cad Saude Publica; 2000; 16(2):421-7. PubMed ID: 10883040
[TBL] [Abstract][Full Text] [Related]
9. Current oral contraceptive use instructions: an analysis of patient package inserts.
Williams-Deane M; Potter LS
Fam Plann Perspect; 1992; 24(3):111-5. PubMed ID: 1628713
[TBL] [Abstract][Full Text] [Related]
10. The multinational drug companies in Zaire: their adverse effect on cost and availability of essential drugs.
Glucksberg H; Singer J
Int J Health Serv; 1982; 12(3):381-7. PubMed ID: 7118328
[TBL] [Abstract][Full Text] [Related]
11. Drug promotion: the Third World revisited.
Silverman M; Lee PR; Lydecker M
Int J Health Serv; 1986; 16(4):659-67. PubMed ID: 2430907
[TBL] [Abstract][Full Text] [Related]
12. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
13. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
Burkhart CG
J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
[No Abstract] [Full Text] [Related]
14. [Patient-oriented package inserts for drugs. Historical overview and current status].
Van Haecht CH; Vander Stichele R; Bogaert M
Arch Belg; 1989; 47(5-6):230-55. PubMed ID: 2700065
[TBL] [Abstract][Full Text] [Related]
15. Commercial drug compendium information: a First World/Third World comparison.
Pleil AM; Pathak DS
Int J Health Serv; 1988; 18(4):587-602. PubMed ID: 3235245
[TBL] [Abstract][Full Text] [Related]
16. [Drug package inserts--varying information for the same medicines].
Storflor JG; Pettersen LC; Slørdal L; Spigset O
Tidsskr Nor Laegeforen; 2013 May; 133(9):955-9. PubMed ID: 23652143
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of Saudi-marketed products and US drug labeling.
Bawazir SA; al-Hassan MI; al-Khamis KI; Abou-Auda HS; Gubara OA
DICP; 1991; 25(7-8):863-6. PubMed ID: 1949946
[TBL] [Abstract][Full Text] [Related]
18. Methodology of OTA's report on drug labeling in developing countries.
Gelband H; Corrigan J; McDonough R
Int J Technol Assess Health Care; 1993; 9(2):238-50. PubMed ID: 8458703
[TBL] [Abstract][Full Text] [Related]
19. Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice.
Fed Regist; 1982 Sep; 47(173):39249-50. PubMed ID: 10258155
[TBL] [Abstract][Full Text] [Related]
20. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
